The view that nuns have a very low risk of cervical cancer is questioned. The historical evidence for this view is reviewed, from the beginning of the eighteenth century to the present. An estimate of the actual mortality rate from cervical cancer suggests that risk of death from this neoplasm among nuns is little different from that among the general female population.
In the May 2006 issue of Obstetrics & Gynecology, the American College of Obstetricians and Gynecologists (ACOG) reaffirmed its recommendation that teenage girls first visit an OB/GYN between the ages of 13 and 15.
A 62-year-old woman of normal body size came to my attention for severe progressive osteoporosis. She had 3 previous vertebral fractures (T10, T11, L1). DEXA scan revealed a BMD T-score of -4.1 on lumbar spine and -3.9 on hip.
During pregnancy, every mother-to-be undergoes radical psychological and physiological changes (endocrinologic, immunologic, metabolic, or vascular) whose influence may trigger various skin manifestations, even during the very first weeks of gestation.
Grief is an emotional, intellectual, physical and spiritual response to loss. The depth and the complexity of grief often feel overwhelming and baffling. Unfortunately, arming ourselves with knowledge about grief does not reduce the depth of grief, nor simplify grief.
Breast cancer awareness campaigns are great, but they should be expanded to provide more clinician education on health disparities and to target women most at risk.
OBGYN.net Conference CoverageFrom World Congress of Perinatal Medicine, Barcelona, Spain, September 23-27, 2001
Yeasts are normally found on body surfaces in low numbers, and they usually do not cause any problems. But when people are exposed to certain risk factors, yeasts can overgrow causing symptomatic infections.
Polycystic ovary syndrome is characterized by anovulation (irregular or absent menstrual periods) and hyperandrogenism (elevated serum testosterone and androstenedione).
One of the most publicized papers of the 1999 American Society of Reproductive Medicine/ Canadian Fertility and Andrology Society was the research presented by Dr. Oktay, Dr. Karkujaya, Dr. Gosden and Dr. Schwartz from Cornell University in New York and and from the University of Leeds in the UK. They successfully auto-transplanted frozen-banked ovarian tissue and demonstrated the resumption of ovarian function.
OBGYN.net Conference CoverageFrom FIGOWashington D.C., USA - September 2000
OBGYN.net Conference CoverageSLS, Society of Laparoendoscopic Surgeons Annual Meeting 13th International Congress and Endo ExpoSeptember 29-October 2, 2004 - New York, New York
OBGYN.net is planning a new section for our web site. We are dedicating a section to both the wellness of women and to general topics of special interest to women. We are starting to develop these new topics here on the Women's Home Page in preparation for the new section, which should be online this summer.
OBGYN.net Broadcasting presents Part III of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.
A Randomized Comparison of Group Cognitive-behavioral Therapy, Surface Electromyographic Biofeedback, andVestibulectomy in the Treatment of Dyspareunia Resulting from Vulvar Vestibulitis
Questions on Contraception answered by Marta Mendez, MD,
OBGYN.net Conference CoverageFrom the European Menopause and Andropause Society (EMAS) 5th Congress, Copenhagen, Denmark-July, 2000
The Contraceptive CHOICE Project, a research study at Washington University in St. Louis, found that offering long-acting, reversible contraception (LARC) to women first, citing its low-failure rates, reduced rates of unintended pregnancy and abortion and increased continuation rates.
OBGYN.net Conference CoverageFrom the 24th Annual American Urogynecology Society Meeting, Hollywood, FL - September 2003
Tumor marker tests include a variety of tests for cancer that can be performed on cells of a tissue sample from a newly biopsied or stored tumor. Tumor marker testing provides the patient and oncologist with vital information about the tumor at the cellular level, expanding traditional pathology reports that are based on tumor size, appearance and staging of the disease.
Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?
Coverage of 36th AAGL Congress November 2007, Washington, DC